FindTrial
Sign In

Study on the relationship between serum irisin level and severity and clinical prognosis in sepsis patients

Study on the relationship between serum irisin level and severity and clinical prognosis in sepsis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055912
Enrollment
Unknown
Registered
2022-01-23
Start date
2022-01-20
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Healthy:none
sepsis:none
septic shock:none

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age > 18; 2.Meet the new definition of sepsis 3.0 diagnostic criteria: Sepsis 3.0 = infection + SOFA score >= 2; 3.All cases had a stay of more than 7 days (except those who died during hospitalization); 4.All selected patients were required to sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients complicated with pregnancy, autoimmune diseases, sarcopenia, and malignant tumors; 2.Patients with acute myocardial infarction, cardiogenic shock or severe chronic disease with organ dysfunction; 3.Patients with predicted survival of less than 28 days due to other medical reasons; 4.The data within 24 hours of admission were incomplete and could not be effectively evaluated.

Design outcomes

Primary

MeasureTime frame
irisin;—

Countries

China

Contacts

Public ContactZhou Jun

Affiliated Hospital of Southwest Medical University

Zhoujun800615@163.com+86 18715816677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026